With the variety of possible risk factors, presentations, impacts, and preferences among individual patients with multiple sclerosis (MS), it has been well-established that every case of MS is unique. It is perhaps because of this that a collaborative, shared decision-making (SDM) approach has emerged as the preferred model of clinical care. However, in an age of over 20 FDA-approved disease modifying therapies (DMTs) and continuously evolving strategies for monitoring therapeutic response, the scope of shared clinical decisions is increasingly broad. Yet, recent studies suggest that this strategy may not yet have taken hold in the routine care of many patients with MS. As such, this activity includes video-recorded stories from real patients referred by the Multiple Sclerosis Foundation to help highlight the importance of SDM alongside key faculty strategies to enhance its application and maximize each therapeutic decision over the course of MS.
- Provider:Partners for Advancing Clinical Education (PACE)
- Activity Link: https://www.mycme.com/courses/evidence-based-treatment-strategies-for-multiple-sclerosis-9336
- Start Date: 2024-03-01 06:00:00
- End Date: 2024-03-01 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Mylan (Any division) - Amount: 155800.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all